Skip to main content

West Pharmaceutical Services Value Stock - Dividend - Research Selection

West pharmaceutical services

ISIN: US9553061055 , WKN: 864330

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Barclays Maintains West Pharmaceutical Services (WST) Equal-Weight Recommendation

2025-10-03

Top 15 High-Growth Dividend Stocks For October 2025

2025-10-01
Read here for an analysis of October 2025’s top 15 high-growth dividend stocks, targeting 12% returns and strong dividend growth.

3 Reasons to Avoid WST and 1 Stock to Buy Instead

2025-09-30
West Pharmaceutical Services has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 16.3% to $260.31 per share while the index has gained 18.6%.

HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis

2025-09-29
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.

3 Profitable Stocks We Steer Clear Of

2025-09-29
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

Best Dividend Aristocrats For October 2025

2025-09-28
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date. Check out the promising dividend aristocrats right now.

TMDX Partners With Mercedes-Benz to Launch Organ Transport Network

2025-09-25
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.

West Pharmaceutical Services (WST) Stock Is Up, What You Need To Know

2025-09-24
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) jumped 3.1% in the afternoon session after a research note from KeyBanc Capital Markets indicated positive momentum in the bioprocessing sector following an industry conference.

West Pharmaceutical Services, Inc. (WST) Presents at Bank of America Global Healthcare Conference 2025 Transcript

2025-09-24
West Pharmaceutical Services, Inc. (NYSE:WST) Bank of America Global Healthcare Conference 2025 September 24, 2025 10:05 AM EDTCompany ParticipantsEric...

STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System

2025-09-23
Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.